Publications citing the R2platfom in 2023

Also 2023, has been quite a successful year for the R2 platform up to now. Citations keep coming in, which are a clear sign to us, that we are still filling a space in the scientific domain, by allowing every researcher to do datamining and datascience analyses and visualizations, without the need for bioinformatics or coding ecpertise.

 

If there are analyses, ideas or other suggestions on how we could improve the R2 platform, then do not hesitate to let us know via the support address on the R2 website (https://r2.amc.nl)

Some recent ctations included in the graph above:

2451	Julson JR et.al. (2023). CDK4/6 Inhibition With Lerociclib is a Potential Therapeutic Strategy for the Treatment of Pediatric Sarcomas. J Pediatr Surg :.
2450	Chen PD et.al. (2023). Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway. Oncogenesis 12:49.
2449	Ali W et.al. (2023). Survival and Enrichment Analysis of Epithelial-Mesenchymal Transition Genes in Bladder Urothelial Carcinoma. Genes (Basel) 14:.
2448	Souza BK et.al. (2023). Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma. Int J Mol Sci 24:.
2447	Rodrigues EM et.al. (2023). The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain Cancer. Cancers (Basel) 15:.
2446	Klonisch T et.al. (2023). DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. Biomolecules 13:.
2445	Babl N et.al. (2023). MCT4 blockade increases the efficacy of immune checkpoint blockade. J Immunother Cancer 11:.
2444	Sun H et.al. (2023). DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia. Technol Cancer Res Treat 22:15330338231207765.
2443	Ferrena A et.al. (2023). SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis. Mol Cancer Ther :.
2442	OBrien E et.al. (2023). Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells. Clin Epigenetics 15:167.
2441	Yang J et.al. (2023). EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail. Cancer Lett :216427.
2440	Lai SW et.al. (2023). Dysregulated expression of slingshot protein phosphatase 1 (SSH1) disrupts circadian rhythm and WNT signaling associated to hepatocellular carcinoma pathogenesis. Aging (Albany NY) 15:.
2439	Martinez de Estibariz I et.al. (2023). The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review. Cancers (Basel) 15:.
2438	Zhang X et.al. (2023). miR-124 and VAMP3 Act Antagonistically in Human Neuroblastoma. Int J Mol Sci 24:.
2437	Scicchitano S et.al. (2023). Zinc Finger 521 Modulates the Nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma. Int J Mol Sci 24:.
2436	Huang YC et.al. (2023). FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression. Biochem Pharmacol :115853.
2435	Mamidi MK et.al. (2023). FCRL1 immunoregulation in B cell development and malignancy. Front Immunol 14:1251127.
2434	Liu N et.al. (2023). The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression. J Exp Clin Cancer Res 42:263.
2433	Wang HY et.al. (2023). High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration. PeerJ 11:e16104.
2432	Barman S et.al. (2023). Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma. J Mol Graph Model 126:108642.
2431	Quan J et.al. (2023). DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity. Environ Toxicol :.
2430	Bahhar I et.al. (2023). The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. Front Immunol 14:1244437.
2429	Le Clorennec C et.al. (2023). USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation. Int J Mol Sci 24:.
2428	Elahi Najafi MA et.al. (2023). GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. Int J Mol Sci 24:.
2427	Ogushi K et.al. (2023). High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma. Cancers (Basel) 15:.
2426	Li D et.al. (2023). Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours. Nat Commun 14:5920.
2425	Ferguson KM et.al. (2023). Palbociclib releases the latent differentiation capacity of neuroblastoma cells. Dev Cell :.
2424	Schafer H et.al. (2023). Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma. J Transl Med 21:643.
2423	Tagay Y et.al. (2023). Dynein-Powered Cell Locomotion Guides Metastasis of Breast Cancer. Adv Sci (Weinh) :e2302229.
2422	Cai L et.al. (2023). Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. Sci Rep 13:15404.
2421	Hao J et.al. (2023). A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance. PLoS Biol 21:e3002256.
2420	Ning J et.al. (2023). The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application. Biomed Pharmacother 167:115456.
2419	Griesinger AM et.al. (2023). Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma. iScience 26:107585.
2418	Ortiz Rivera J et.al. (2023). Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model. Int J Mol Sci 24:.
2417	Ye F et.al. (2023). Antileukemic effect of venetoclax and hypomethylating agents via caspase-3/GSDME-mediated pyroptosis. J Transl Med 21:606.
2416	Grand-Guillaume J et.al. (2023). CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake ((123/131)I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors. J Transl Med 21:604.
2415	Hsieh CH et.al. (2023). Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma. Biomed Pharmacother 166:115429.
2414	Wang C et.al. (2023). ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy. Nat Metab :.
2413	Huang Q et.al. (2023). DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer. iScience 26:107606.
2412	Shinzawa K et.al. (2023). GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation. Oncogene :.
2411	Picard D et.al. (2023). Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma. Acta Neuropathol :.
2410	Hounjet J et.al. (2023). Iron-responsive element of Divalent metal transporter 1 (Dmt1) controls Notch-mediated cell fates. FEBS J :.
2409	Spaan CN et.al. (2023). Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis. Life Sci Alliance 6:.
2408	Wang Y et.al. (2023). Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging. Korean J Radiol 24:871-889.
2407	Zhang C et.al. (2023). Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer. Cell Oncol (Dordr) :.
2406	Zhang Y et.al. (2023). MKRN1 promotes colorectal cancer metastasis by activating the TGF-beta signalling pathway through SNIP1 protein degradation. J Exp Clin Cancer Res 42:219.
2405	Wang Y et.al. (2023). Acute cigarette smoke exposure leads to higher viral infection in human bronchial epithelial cultures by altering interferon, glycolysis and GDF15-related pathways. Respir Res 24:207.
2404	Zhang HF et.al. (2023). A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma. Sci Adv 9:eadg6693.
2403	Wu HW et.al. (2023). DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker. iScience 26:107269.
2402	Malik N et.al. (2023). Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221-3p/222-3p axis in glioblastoma. Mol Carcinog :.
2401	Di Fiore A et.al. (2023). KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors. Neoplasia 43:100926.
2400	Khan GH et.al. (2023). Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response. Eur J Immunol :e2350562.
2399	Steen E et.al. (2023). Targeting the RET tyrosine kinase in neuroblastoma: a review and application of a novel selective drug design strategy. Biochem Pharmacol :115751.
2398	Ariey-Bonnet J et.al. (2023). Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms. EBioMedicine 95:104752.
2397	Lei FJ et.al. (2023). Cellular and exosomal GPx1 are essential for controlling hydrogen peroxide balance and alleviating oxidative stress in hypoxic glioblastoma. Redox Biol 65:102831.
2396	Pilgrim AA et.al. (2023). The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1. Oncoimmunology 12:2240678.
2395	Roy A et.al. (2023). Using evolutionary constraint to define novel candidate driver genes in medulloblastoma. Proc Natl Acad Sci U S A 120:e2300984120.
2394	Hartley R et.al. (2023). MYC promotes aggressive growth and metastasis of a WNT-medulloblastoma mouse model. Dev Neurosci :.
2393	Zhang X et.al. (2023). Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN. Cell Death Dis 14:504.
2392	Li Y et.al. (2023). Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma. Cell Death Dis 14:494.
2391	Thakur K et.al. (2023). Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control. Biochim Biophys Acta Mol Basis Dis 1869:166817.
2390	Takahashi S et.al. (2023). ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1. Sci Rep 13:12355.
2389	Zaghmi A et.al. (2023). High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance. Mol Oncol :.
2388	de Araujo MA et.al. (2023). Low Expression of the NRP1 Gene Is Associated with Shorter Overall Survival in Patients with Sonic Hedgehog and Group 3 Medulloblastoma. Int J Mol Sci 24:.
2387	Orozco CA et.al. (2023). Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma. Biomolecules 13:.
2386	Sigaud R et.al. (2023). MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas. Nat Commun 14:4533.
2385	Man YN et.al. (2023). TAF1D Functions as a Novel Biomarker in Osteosarcoma. J Cancer 14:2051-2065.
2384	Mallard HJ et.al. (2023). USP1 expression driven by EWS::FLI1 transcription factor stabilizes Survivin and mitigates replication stress in Ewing sarcoma. Mol Cancer Res :.
2383	Chakraborty S et.al. (2023). EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Commun Biol 6:758.
2382	Wrenn ED et.al. (2023). Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment. Clin Cancer Res :.
2381	Karakaya S et.al. (2023). Cytoplasmic HIF-2alpha as tissue biomarker to identify metastatic sympathetic paraganglioma. Sci Rep 13:11588.
2380	Zhou Y et.al. (2023). CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma. Clin Transl Med 13:e1328.
2379	Chagas PS et.al. (2023). Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells. Hum Cell :.
2378	Huang CY et.al. (2023). Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the beta-Catenin-RUNX2 Axis. Int J Mol Sci 24:.
2377	Slapak EJ et.al. (2023). Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. Int J Mol Sci 24:.
2376	Khazan N et.al. (2023). Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1. Cancers (Basel) 15:.
2375	Liu J et.al. (2023). Transcriptome Profiling of Goose Ovarian Follicle Granulosa Cells Reveals Key Regulatory Networks for Follicle Selection. Animals (Basel) 13:.
2374	Agnello L et.al. (2023). Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells. Cells 12:.
2373	Sun Y et.al. (2023). FAM60A promotes osteosarcoma development and progression. Cancer Med :.
2372	Hou J et.al. (2023). NCAPG promotes the progression of glioblastoma by facilitating PARP1-mediated E2F1 transactivation. Neuro Oncol :.
2371	Laub V et.al. (2023). Bioinformatics for wet-lab scientists: practical application in sequencing analysis. BMC Genomics 24:382.
2370	Bisaccia J et.al. (2023). The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas. Cell Death Discov 9:230.
2369	Fang M et.al. (2023). E3 ligase MG53 suppresses tumor growth by degrading cyclin D1. Signal Transduct Target Ther 8:263.
2368	Gunnarsdottir FB et.al. (2023). Breast cancer associated CD169(+) macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells. Front Immunol 14:1180209.
2367	Zhang B et.al. (2023). Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping. Acta Pharmacol Sin :.
2366	Fuchs S et.al. (2023). Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. Nat Commun 14:3936.
2365	Braganhol E et.al. (2023). ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis. Purinergic Signal :.
2364	Pu J et.al. (2023). N(6) -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A. Cancer Sci :.
2363	Li Z et.al. (2023). False discovery rate control in cancer biomarker selection. Genes Dis 10:1141-1142.
2362	Wei PL et.al. (2023). PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway. Int J Mol Sci 24:.
2361	Lin X et.al. (2023). Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3. Cancers (Basel) 15:.
2360	van Driel MS et.al. (2023). Caffeine Limits Expansion of Apc-Deficient Clones in the Intestine by NOTUM Inhibition. Cell Mol Gastroenterol Hepatol :.
2359	Zhang H et.al. (2023). Inhibition of TAZ impairs the migration ability of melanoma cells. Open Life Sci 18:20220633.
2358	Cifaldi L et.al. (2023). DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy. Front Immunol 14:1197053.
2357	Pan R et.al. (2023). PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. Cell Death Dis 14:373.
2356	Chang J et.al. (2023). Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children. J Cell Mol Med 27:2239-2248.
2355	Matsumoto S et.al. (2023). Wnt Signaling Stimulates Cooperation between GREB1 and HNF4alpha to Promote Proliferation in Hepatocellular Carcinoma. Cancer Res 83:2312-2327.
2354	Lee JY et.al. (2023). Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Rep Med 4:101091.
2353	Wu W et.al. (2023). Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. EBioMedicine 93:104650.
2352	Shahab SW et.al. (2023). The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. Mol Oncol :.
2351	Fan C et.al. (2023). The lncRNA LETS1 promotes TGF-beta-induced EMT and cancer cell migration by transcriptionally activating a TbetaR1-stabilizing mechanism. Sci Signal 16:eadf1947.
2350	Di Matteo S et.al. (2023). The roles of different forms of IL-15 in human melanoma progression. Front Immunol 14:1183668.
2349	Litzler LC et.al. (2023). Protein arginine methyltransferase 1 regulates B cell fate after positive selection in the germinal center in mice. J Exp Med 220:.
2348	Di Pace AL et.al. (2023). MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells. Oncoimmunology 12:2221081.
2347	Fanlo L et.al. (2023). Neural crest-related NXPH1/alpha-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis. Oncogene 42:2218-2233.
2346	Chen C et.al. (2023). Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma. Cell Signal 109:110753.
2345	Saggioro M et.al. (2023). A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features. Sci Rep 13:9444.
2344	Broso F et.al. (2023). Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation. Cancer Res 83:2733-2749.
2343	Al-Jamaei AAH et.al. (2023). A narrative review of the role of Eph receptors in head and neck squamous cell carcinoma. Oral Dis :.
2342	Nirala BK et.al. (2023). MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma. JCI Insight 8:.
2341	Young IC et.al. (2023). Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways. Cancer Gene Ther :.
2340	Hagemann S et.al. (2023). IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression. Mol Cancer 22:88.
2339	Nikolic A et.al. (2023). macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma. Nat Commun 14:3062.
2338	DeMartino J et.al. (2023). Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma. Nat Commun 14:3074.
2337	Almutairi BO et.al. (2023). HSPB6 Is Depleted in Colon Cancer Patients and Its Expression Is Induced by 5-aza-2-Deoxycytidine In Vitro. Medicina (Kaunas) 59:.
2336	Li M et.al. (2023). FTO Promotes the Stemness of Gastric Cancer Cells. DNA Cell Biol 42:411-420.
2335	Tedjawirja VN et.al. (2023). Exploring the expression and potential function of follicle stimulating hormone receptor in extragonadal cells related to abdominal aortic aneurysm. PLoS One 18:e0285607.
2334	Mondal I et.al. (2023). PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma. Cancer Res 83:2527-2542.
2333	Goda C et.al. (2023). Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma. Exp Hematol 123:28-33.e3.
2332	Cuesta-Casanovas L et.al. (2023). Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia. Cancer Cell Int 23:97.
2331	Wang Z et.al. (2023). METTL1/WDR4-mediated tRNA m(7)G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene 42:1900-1912.
2330	Zhou Q et.al. (2023). Multi-Omics Analysis of the Prognostic and Immunological Role of Runt-Related Transcription Factor 3 in Pan-Cancer. Crit Rev Eukaryot Gene Expr 33:63-83.
2329	Valinciute G et.al. (2023). Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells. J Neurooncol 163:143-158.
2328	Anantha J et.al. (2023). A combined proteomics and bioinformatics analysis of ZNHIT1-interacting proteins reveals a significant enrichment in proteins associated with mitochondrial function. J Chem Neuroanat 131:102288.
2327	Agarwal P et.al. (2023). MYCN Amplification Is Associated with Reduced Expression of Genes Encoding gamma-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. Int J Mol Sci 24:.
2326	Yang JT et.al. (2023). ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. Int J Mol Sci 24:.
2325	Bruss C et.al. (2023). Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion. Cancers (Basel) 15:.
2324	Jackson HK et.al. (2023). Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner. Cancers (Basel) 15:.
2323	Alcantara JH et.al. (2023). Global trends, gaps, and future agenda in medulloblastoma research: a bibliometric analysis. Childs Nerv Syst :.
2322	Karapurkar JK et.al. (2023). CRISPR/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis. J Exp Clin Cancer Res 42:121.
2321	Ribeiro ML et.al. (2023). G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kdeltai dual therapy. Front Immunol 14:1130052.
2320	Tong W et.al. (2023). CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. J Cancer 14:916-926.
2319	Choi JH et.al. (2023). SEC22B inhibition attenuates colorectal cancer aggressiveness and autophagic flux under unfavorable environment. Biochem Biophys Res Commun 665:10-18.
2318	Guo P et.al. (2023). A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Sci Adv 9:eabq7866.
2317	Martell E et.al. (2023). Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma. Nat Commun 14:2502.
2316	Power EA et.al. (2023). Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time. Neurooncol Adv 5:vdad033.
2315	Koufaris C et.al. (2023). miR-22-enriched breast cancer cells display repressed glycolytic metabolism, increased glycogen synthesis, and reduced survival in low glucose conditions. Mol Biol Rep 50:5185-5193.
2314	Shishido K et.al. (2023). Targeting B7‑H3 through EZH2 inhibition in MYC‑positive Group 3 medulloblastoma. Oncol Rep 49:.
2313	Lee M et.al. (2023). Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers. Int J Stem Cells 16:215-233.
2312	Ortega-Campos SM et.al. (2023). Interactions of circadian clock genes with the hallmarks of cancer. Biochim Biophys Acta Rev Cancer 1878:188900.
2311	Kavazovic I et.al. (2023). Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cells. Cell Rep 42:112395.
2310	Zhang X et.al. (2023). TAF1D promotes proliferation by transcriptionally activating G2/M phase-related genes in MYCN-amplified neuroblastoma. Cancer Sci 114:2860-2870.
2309	Korshunov A et.al. (2023). Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes. Acta Neuropathol 145:829-842.
2308	Okonechnikov K et.al. (2023). 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma. Nat Commun 14:2300.
2307	Qiao R et.al. (2023). Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation. Mol Cancer Res 21:825-835.
2306	Zhang C et.al. (2023). Mapping the Response of Human Osteocytes in Native Matrix to Mechanical Loading Using RNA Sequencing. JBMR Plus 7:e10721.
2305	Alamoudi AA et.al. (2023). SOX9 Expression Is Increased in Alzheimers Disease (AD) and Is Associated With Disease Progression and APOE4 Genotype: A Computational Approach. Cureus 15:e36129.
2304	Lin Z et.al. (2023). Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Cancer Res 83:2187-2207.
2303	Tran GB et.al. (2023). Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma. Cancer Res 83:2248-2261.
2302	Zhou J et.al. (2023). RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma. Mol Oncol :.
2301	Nagoya A et.al. (2023). CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer. Transl Lung Cancer Res 12:408-426.
2300	Langlois S et.al. (2023). Inhibition of PANX1 Channels Reduces the Malignant Properties of Human High-Risk Neuroblastoma. J Cancer 14:689-706.
2299	Schoenmaker T et.al. (2023). Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. Int J Mol Sci 24:.
2298	Luca S et.al. (2023). PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype. Cancers (Basel) 15:.
2297	Ognibene M et.al. (2023). Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis. Cancers (Basel) 15:.
2296	de Sousa GR et.al. (2023). Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Ther 30:1105-1113.
2295	Bhavsar SP et.al. (2023). Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells. Front Pediatr 11:1098999.
2294	Xu C et.al. (2023). Macrophages facilitate tumor cell PD-L1 expression via an IL-1beta-centered loop to attenuate immune checkpoint blockade. MedComm (2020) 4:e242.
2293	Lansbergen MF et.al. (2023). Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review. Crit Rev Oncol Hematol 185:103982.
2292	Chornyi S et.al. (2023). The origin of long-chain fatty acids required for de novo ether lipid/plasmalogen synthesis. J Lipid Res 64:100364.
2291	Kaess C et.al. (2023). Evaluating the RIST Molecular-Targeted Regimen in a Three-Dimensional Neuroblastoma Spheroid Cell Culture Model. Cancers (Basel) 15:.
2290	Aschero R et.al. (2023). Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma. Pediatr Blood Cancer 70:e30318.
2289	Dhamdhere MR et.al. (2023). IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis. Oncogene 42:1558-1571.
2288	Yuan L et.al. (2023). Arsenic resistance protein 2 and microRNA biogenesis: Biological implications in cancer development. Pharmacol Ther 244:108386.
2287	Kimman T et.al. (2023). Serpin B9 controls tumor cell killing by CAR T cells. J Immunother Cancer 11:.
2286	Lee CC et.al. (2023). In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. Sci Rep 13:4366.
2285	Jin Q et.al. (2023). MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3. Technol Cancer Res Treat 22:15330338231157156.
2284	Zhang S et.al. (2023). Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma. Acta Biochim Biophys Sin (Shanghai) 55:356-366.
2283	Pan G et.al. (2023). Aerobic glycolysis in colon cancer is repressed by naringin via the HIF1Alpha pathway. J Zhejiang Univ Sci B 24:221-231.
2282	Nasehi R et.al. (2023). 3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model. Mater Today Bio 19:100596.
2281	Julson JR et.al. (2023). Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype. J Pediatr Surg 58:1155-1163.
2280	Veschi V et.al. (2023). Recapitulating thyroid cancer histotypes through engineering embryonic stem cells. Nat Commun 14:1351.
2279	Kucukkose E et.al. (2023). Lymphatic Invasion of Plakoglobin-Dependent Tumor Cell Clusters Drives Formation of Polyclonal Lung Metastases in Colon Cancer. Gastroenterology 165:429-444.e15.
2278	Citarella A et.al. (2023). Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy. Cancers (Basel) 15:.
2277	Carna M et.al. (2023). Missorting of plasma miRNAs in aging and Alzheimers disease. J Neurochem 165:149-161.
2276	Decaesteker B et.al. (2023). SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. Nat Commun 14:1267.
2275	Tomolonis JA et.al. (2023). Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-alpha triggers tumorigenic inflammation in neuroblastoma. J Immunother Cancer 11:.
2274	Rapetti-Mauss R et.al. (2023). SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer. Gut 72:722-735.
2273	Liu Y et.al. (2023). Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis. Cancer Med 12:10768-10780.
2272	Chicco D et.al. (2023). Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma. BioData Min 16:7.
2271	Bruno G et.al. (2023). beta3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-gamma-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma. Cancer Gene Ther 30:890-904.
2270	Ge L et.al. (2023). MESP2 binds competitively to TCF4 to suppress gastric cancer progression by regulating the SKP2/p27 axis. Cell Death Discov 9:79.
2269	Zou H et.al. (2023). A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis. Nat Cell Biol 25:493-507.
2268	Schultz CR et.al. (2023). New K50R mutant mouse models reveal impaired hypusination of eif5a2 with alterations in cell metabolite landscape. Biol Open 12:.
2267	Candido MF et.al. (2023). Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario. Pharmaceutics 15:.
2266	Ognibene M et.al. (2023). A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers (Basel) 15:.
2265	Taylor L et.al. (2023). Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature. Cancers (Basel) 15:.
2264	Marques RF et.al. (2023). Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Front Immunol 14:1062856.
2263	Liu S et.al. (2023). Differential optineurin expression controls TGFbeta signaling and is a key determinant for metastasis of triple negative breast cancer. Int J Cancer 152:2594-2606.
2262	Ke S et.al. (2023). NKD2 Trigger NF-kappaB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation. Mol Biotechnol :.
2261	Zhang J et.al. (2023). PDLIM3 supports hedgehog signaling in medulloblastoma by facilitating cilia formation. Cell Death Differ 30:1198-1210.
2260	Klonou A et.al. (2023). Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis. J Mol Med (Berl) 101:387-401.
2259	Seok J et.al. (2023). Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer. J Transl Med 21:129.
2258	Panosyan WS et.al. (2023). Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma. Pediatr Res 94:458-461.
2257	Biswas PK et.al. (2023). The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway. Int J Mol Sci 24:.
2256	Timpanaro A et.al. (2023). Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. Int J Mol Sci 24:.
2255	Perrone C et.al. (2023). Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation. Front Cell Dev Biol 11:1061570.
2254	Koeniger A et.al. (2023). Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment. NAR Cancer 5:zcad007.
2253	Danielli SG et.al. (2023). Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Sci Adv 9:eade9238.
2252	Lu Y et.al. (2023). High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma via the NF-kappaB Pathway in MG63 Cells. Curr Cancer Drug Targets 23:496-504.
2251	Cheng C et.al. (2023). P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma. Mol Cell Proteomics 22:100504.
2250	Wibowo BP et.al. (2023). The Effect of Salmonella AvrA Infection on Colon Cancer: An in-silico Study. Asian Pac J Cancer Prev 24:163-170.
2249	Qi D et.al. (2023). Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers. NPJ Genom Med 8:2.
2248	Stamatiou K et.al. (2023). CCDC86 is a novel Ki-67-interacting protein important for cell division. J Cell Sci 136:.
2247	Cai J et.al. (2023). AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-kappaB activation. Cell Biosci 13:15.
2246	Mei W et.al. (2023). IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms. J Adv Res :.
2245	Gomez-Munoz MA et.al. (2023). Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness. Int J Mol Sci 24:.
2244	Hartl L et.al. (2023). C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. Int J Mol Sci 24:.
2243	Arseni L et.al. (2023). Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression. Cancers (Basel) 15:.
2242	Sinclair PB et.al. (2023). Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia. Leukemia 37:636-649.
2241	Bakr MN et.al. (2023). CHRNA1 and its correlated-myogenesis/cell cycle genes are prognosis-related markers of metastatic melanoma. Biochem Biophys Rep 33:101425.
2240	Lak NSM et.al. (2023). Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma. JCO Precis Oncol 7:e2200113.
2239	Maklad A et.al. (2023). LIN28 expression and function in medulloblastoma. J Cell Physiol 238:533-548.
2238	Wetzel TJ et.al. (2023). The emerging role of the branched chain aminotransferases, BCATc and BCATm, for anti-tumor T-cell immunity. Immunometabolism (Cobham) 5:e00014.
2237	Wang F et.al. (2023). Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours. BMC Cancer 23:44.
2236	Okonechnikov K et.al. (2023). Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses. Acta Neuropathol Commun 11:7.
2235	Linke F et.al. (2023). Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging. Acta Neuropathol Commun 11:6.
2234	Stehle D et.al. (2023). Heterogeneity of cGMP signalling in tumour cells and the tumour microenvironment: Challenges and chances for cancer pharmacology and therapeutics. Pharmacol Ther 242:108337.
2233	Lin Y et.al. (2023). PLAGL2 promotes the stemness and is upregulated by transcription factor E2F1 in human lung cancer. Environ Toxicol 38:941-949.
2232	Trinidad EM et.al. (2023). Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA. Brief Bioinform 24:.
2231	Wang R et.al. (2023). ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis. Sci Adv 9:eabq3951.
2230	He Z et.al. (2023). Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer. J Cancer 14:72-87.
2229	Martinez-Monleon A et.al. (2023). Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma. Int J Oncol 62:.
2228	Chen KS et.al. (2023). Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Sci Transl Med 15:eabo4778.
2227	van Wouw SAE et.al. (2023). Sterol-regulated transmembrane protein TMEM86a couples LXR signaling to regulation of lysoplasmalogens in macrophages. J Lipid Res 64:100325.
2226	Sanders K et.al. (2023). Transcriptome sequencing reveals two subtypes of cortisol-secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target. Vet Comp Oncol 21:100-110.
2225	Blomberg E et.al. (2023). Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models. Transl Oncol 28:101607.
2224	Palombo R et.al. (2023). Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma. Cancer Lett 555:216042.
2223	Contadini C et.al. (2023). Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy. Cell Death Differ 30:417-428.
2222	Xu G et.al. (2023). C-Fos-activated circRPPH1 contributes to glioma stemness. Clin Transl Oncol 25:1277-1286.
2221	Ali W et.al. (2023). Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma. Arch Biochem Biophys 733:109470.
2220	Keck MK et.al. (2023). Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathol 145:49-69.
2219	Shen Y et.al. (2023). Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma. Mol Biol Rep 50:1167-1180.
2218	Tippett VL et.al. (2023). The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. Oncogene 42:259-277.
2217	Formicola D et.al. (2023). CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity. HGG Adv 4:100158.
2216	Zhang S et.al. (2023). NONO enhances mRNA processing of super-enhancer-associated GATA2 and HAND2 genes in neuroblastoma. EMBO Rep 24:e54977.
2215	Evans RJ et.al. (2023). Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of Sarcoma. Mol Cancer Ther 22:240-253.
2214	Pettitt GA et.al. (2023). Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro. J Pathol 259:220-232.
2213	Mo J et.al. (2023). Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex. Oncogene 42:11-25.
2212	Lee CJ et.al. (2023). Machine learning with in silico analysis markedly improves survival prediction modeling in colon cancer patients. Cancer Med 12:7603-7615.
2211	Pulido R et.al. (2023). Hopes on immunotherapy targeting B7-H3 in neuroblastoma. Transl Oncol 27:101580.
2210	Ouahoud S et.al. (2023). Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development. J Gastroenterol 58:25-43.
2209	Bloedjes TA et.al. (2023). AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity. Blood Adv 7:1697-1712.
2208	Jiang H et.al. (2023). Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res 83:181-194.
2207	Lin Z et.al. (2023). N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Mol Ther 31:517-534.
2206	Nakata S et.al. (2023). Epigenetic upregulation of Schlafen11 renders WNT Neuro Oncol 25:899-912.
2205	Tsujimoto A et.al. (2023). Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Cancer Med 12:5821-5832.
2204	Chang G et.al. (2023). USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5. Neuro Oncol 25:841-853.
2203	Thus YJ et.al. (2023). Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation. Haematologica 108:797-810.
2202	Korovina I et.al. (2023). Targeting integrin alpha2 as potential strategy for radiochemosensitization of glioblastoma. Neuro Oncol 25:648-661.
2201	Yang R et.al. (2023). Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression. Neuro Oncol 25:635-647.
2200	Subramanian C et.al. (2023). Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival. Surgery 173:43-51.
2199	Liu J et.al. (2023). CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis. Environ Toxicol 38:115-125.
2198	Rosch L et.al. (2023). ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein. Mol Oncol 17:37-58.
2197	Li J et.al. (2023). ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth. Cancer Immunol Immunother 72:903-916.
2196	Wei ST et.al. (2023). Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma. Cancer Sci 114:174-186.
2195	Al-Jamaei AAH et.al. (2023). Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines. J Cancer Res Clin Oncol 149:4173-4184.
2194	Vriend J et.al. (2023). Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin. Cell Mol Neurobiol 43:1425-1452.
2193	Wang W et.al. (2023). N(6) -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion. Cancer Med 12:3731-3743.
2192	Chen L et.al. (2023). DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression. Pediatr Res 93:852-861.
2191	Fratini L et.al. (2023). ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma. Neuromolecular Med 25:64-74.
2190	Martins-da-Silva A et.al. (2023). Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma. Cell Mol Neurobiol 43:813-826.
2189	Jain D et.al. (2023). Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance. Cell Biol Toxicol 39:967-989.